1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Designed	_	_	VBN	_	_	_	_	_
2	scaffolds	_	_	NNS	_	_	_	_	_
3	should	_	_	MD	_	_	_	_	_
4	be	_	_	VB	_	_	_	_	_
5	biocompatible	_	_	JJ	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	biodegradable	_	_	JJ	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	capable	_	_	JJ	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	producing	_	_	VBG	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	extracellular	_	_	JJ	_	_	_	_	_
14	matrix	_	_	NN	_	_	_	_	_
15	(	_	_	-LRB-	_	_	_	_	_
16	ECM	_	_	NN	_	_	_	_	_
17	)	_	_	-RRB-	_	_	_	_	_
18	by	_	_	IN	_	_	_	_	_
19	supporting	_	_	VBG	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	cell	_	_	NN	_	_	_	_	_
22	’s	_	_	POS	_	_	_	_	_
23	adhesion	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	proliferation	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	should	_	_	MD	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	have	_	_	VB	_	_	_	_	_
5	porosity	_	_	NN	_	_	_	_	_
6	to	_	_	TO	_	_	_	_	_
7	promote	_	_	VB	_	_	_	_	_
8	nutrient	_	_	NN	_	_	_	_	_
9	transportation	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	their	_	_	PRP$	_	_	_	_	_
13	mechanical	_	_	JJ	_	_	_	_	_
14	properties	_	_	NNS	_	_	_	_	_
15	should	_	_	MD	_	_	_	_	_
16	be	_	_	VB	_	_	_	_	_
17	similar	_	_	JJ	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	native	_	_	JJ	_	_	_	_	_
20	tissue	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	meet	_	_	VB	_	_	_	_	_
3	these	_	_	DT	_	_	_	_	_
4	requirements	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	high	_	_	JJ	_	_	_	_	_
8	surface	_	_	NN	_	_	_	_	_
9	area	_	_	NN	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	an	_	_	DT	_	_	_	_	_
12	interconnected	_	_	VBN	_	_	_	_	_
13	three-dimensional	_	_	JJ	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	3D	_	_	NNP	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	porous	_	_	JJ	_	_	_	_	_
18	structure	_	_	NN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	sizes	_	_	NNS	_	_	_	_	_
21	ranging	_	_	VBG	_	_	_	_	_
22	between	_	_	IN	_	_	_	_	_
23	200	_	_	CD	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	600	_	_	CD	_	_	_	_	_
26	μm	_	_	NNS	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	essential	_	_	JJ	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	while	_	_	IN	_	_	_	_	_
31	also	_	_	RB	_	_	_	_	_
32	providing	_	_	VBG	_	_	_	_	_
33	nutrient	_	_	NN	_	_	_	_	_
34	transfer	_	_	NN	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	waste	_	_	NN	_	_	_	_	_
37	disposal	_	_	NN	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	cellular	_	_	JJ	_	_	_	_	_
40	infiltration	_	_	NN	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	neovascularization	_	_	NN	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	and	_	_	CC	_	_	_	_	_
45	cell	_	_	NN	_	_	_	_	_
46	proliferation	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Natural	_	_	JJ	_	_	_	_	_
2	polymers	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	preferred	_	_	VBN	_	_	_	_	_
5	materials	_	_	NNS	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	producing	_	_	VBG	_	_	_	_	_
8	scaffolds	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	their	_	_	PRP$	_	_	_	_	_
13	better	_	_	JJR	_	_	_	_	_
14	overall	_	_	JJ	_	_	_	_	_
15	interactions	_	_	NNS	_	_	_	_	_
16	with	_	_	IN	_	_	_	_	_
17	various	_	_	JJ	_	_	_	_	_
18	cell	_	_	NN	_	_	_	_	_
19	types	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	their	_	_	PRP$	_	_	_	_	_
23	lack	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	toxicity	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	synthetic	_	_	JJ	_	_	_	_	_
4	polymers	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	cheaper	_	_	JJR	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	allow	_	_	VB	_	_	_	_	_
9	chemical	_	_	JJ	_	_	_	_	_
10	functionalization	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	assist	_	_	VB	_	_	_	_	_
13	cell	_	_	NN	_	_	_	_	_
14	adhesion	_	_	NN	_	_	_	_	_
15	despite	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	immune	_	_	JJ	_	_	_	_	_
18	response	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	preferred	_	_	VBN	_	_	_	_	_
3	synthetic	_	_	JJ	_	_	_	_	_
4	polymers	_	_	NNS	_	_	_	_	_
5	used	_	_	VBN	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	scaffold	_	_	NN	_	_	_	_	_
8	synthesis	_	_	NN	_	_	_	_	_
9	include	_	_	VBP	_	_	_	_	_
10	poly(l-lactic	_	_	JJ	_	_	_	_	_
11	acid	_	_	NN	_	_	_	_	_
12	)	_	_	-RRB-	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	PLLA	_	_	NN	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	poly(glycolic	_	_	JJ	_	_	_	_	_
18	acid	_	_	NN	_	_	_	_	_
19	)	_	_	-RRB-	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	PGA	_	_	NN	_	_	_	_	_
22	)	_	_	-RRB-	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	poly(caprolactone	_	_	NN	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	(	_	_	-LRB-	_	_	_	_	_
27	PCL	_	_	NN	_	_	_	_	_
28	)	_	_	-RRB-	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	poly(lactic-	_	_	FW	_	_	_	_	_
32	co	_	_	NN	_	_	_	_	_
33	-glycolic	_	_	NN	_	_	_	_	_
34	)	_	_	-RRB-	_	_	_	_	_
35	acid	_	_	NN	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	PLGA	_	_	NN	_	_	_	_	_
38	)	_	_	-RRB-	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Composites	_	_	NNS	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	natural	_	_	JJ	_	_	_	_	_
4	polymers	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	also	_	_	RB	_	_	_	_	_
7	available	_	_	JJ	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	better	_	_	JJR	_	_	_	_	_
10	hydrophilicity	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	cell	_	_	NN	_	_	_	_	_
13	attachment	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	biodegradability	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	most	_	_	RBS	_	_	_	_	_
3	used	_	_	VBN	_	_	_	_	_
4	biopolymers	_	_	NNS	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	chitosan	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	alginate	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	Alg	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	collagen	_	_	NN	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	Col	_	_	NNP	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	gelatin	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	Gn	_	_	NN	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	silk	_	_	NN	_	_	_	_	_
24	fibroin	_	_	NN	_	_	_	_	_
25	(	_	_	-LRB-	_	_	_	_	_
26	SF	_	_	NN	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	glycosaminoglycans	_	_	NNS	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	GAGs	_	_	NNS	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Chitosan	_	_	NNP	_	_	_	_	_
2	(	_	_	-LRB-	_	_	_	_	_
3	CS	_	_	NNP	_	_	_	_	_
4	)	_	_	-RRB-	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	natural	_	_	JJ	_	_	_	_	_
8	polymer	_	_	NN	_	_	_	_	_
9	obtained	_	_	VBN	_	_	_	_	_
10	from	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	partial	_	_	JJ	_	_	_	_	_
13	deacetylation	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	chitin	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	is	_	_	VBZ	_	_	_	_	_
18	one	_	_	CD	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	most	_	_	RBS	_	_	_	_	_
22	common	_	_	JJ	_	_	_	_	_
23	biopolymers	_	_	NNS	_	_	_	_	_
24	on	_	_	IN	_	_	_	_	_
25	earth	_	_	NN	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	present	_	_	JJ	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	shells	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	crustaceans	_	_	NNS	_	_	_	_	_
9	such	_	_	JJ	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	crab	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	shrimp	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	CS	_	_	NNP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	many	_	_	JJ	_	_	_	_	_
4	desirable	_	_	JJ	_	_	_	_	_
5	properties	_	_	NNS	_	_	_	_	_
6	for	_	_	IN	_	_	_	_	_
7	tissue	_	_	NN	_	_	_	_	_
8	engineering	_	_	NN	_	_	_	_	_
9	such	_	_	JJ	_	_	_	_	_
10	as	_	_	IN	_	_	_	_	_
11	biocompatibility	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	non-toxicity	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	biodegradability	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	CS	_	_	NNP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	used	_	_	VBN	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	several	_	_	JJ	_	_	_	_	_
6	tissue-engineering	_	_	JJ	_	_	_	_	_
7	applications	_	_	NNS	_	_	_	_	_
8	involving	_	_	VBG	_	_	_	_	_
9	bone	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	cartilage	_	_	NN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	liver	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	tendons	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	ligaments	_	_	NNS	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	nerves	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	wound	_	_	NN	_	_	_	_	_
22	healing	_	_	NN	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	separation	_	_	NN	_	_	_	_	_
25	membranes	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	blood	_	_	NN	_	_	_	_	_
28	anticoagulants	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	contact	_	_	NN	_	_	_	_	_
31	lenses	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	controlled	_	_	VBN	_	_	_	_	_
34	release	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	drugs	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	fat-sequestering	_	_	JJ	_	_	_	_	_
39	agent	_	_	NN	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	hydrogel	_	_	NN	_	_	_	_	_
42	preparations	_	_	NNS	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	and	_	_	CC	_	_	_	_	_
45	food	_	_	NN	_	_	_	_	_
46	packaging	_	_	NN	_	_	_	_	_
47	material	_	_	NN	_	_	_	_	_
48	.	_	_	.	_	_	_	_	_


1	CS	_	_	NNP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	evaluated	_	_	VBN	_	_	_	_	_
4	for	_	_	IN	_	_	_	_	_
5	bone	_	_	NN	_	_	_	_	_
6	tissue	_	_	NN	_	_	_	_	_
7	engineering	_	_	NN	_	_	_	_	_
8	(	_	_	-LRB-	_	_	_	_	_
9	BTE	_	_	NN	_	_	_	_	_
10	)	_	_	-RRB-	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	good	_	_	JJ	_	_	_	_	_
13	cell	_	_	NN	_	_	_	_	_
14	adhesion	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	proliferation	_	_	NN	_	_	_	_	_
17	observed	_	_	VBD	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	CS	_	_	NN	_	_	_	_	_
2	composites	_	_	NNS	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	different	_	_	JJ	_	_	_	_	_
5	materials	_	_	NNS	_	_	_	_	_
6	such	_	_	JJ	_	_	_	_	_
7	as	_	_	IN	_	_	_	_	_
8	ceramics	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	nanofillers	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	polymers	_	_	NNS	_	_	_	_	_
14	were	_	_	VBD	_	_	_	_	_
15	evaluated	_	_	VBN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	BTE	_	_	NN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	excellent	_	_	JJ	_	_	_	_	_
20	biocompatibility	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	cell	_	_	NN	_	_	_	_	_
23	proliferation	_	_	NN	_	_	_	_	_
24	results	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	recognized	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	amine	_	_	NN	_	_	_	_	_
6	and	_	_	CC	_	_	_	_	_
7	hydroxyl	_	_	NN	_	_	_	_	_
8	groups	_	_	NNS	_	_	_	_	_
9	facilitate	_	_	VBP	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	addition	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	side	_	_	NN	_	_	_	_	_
14	groups	_	_	NNS	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	cell	_	_	NN	_	_	_	_	_
17	incorporation	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	recognition	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	BTE	_	_	NNP	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	like	_	_	IN	_	_	_	_	_
4	many	_	_	JJ	_	_	_	_	_
5	other	_	_	JJ	_	_	_	_	_
6	polysaccharides	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	it	_	_	PRP	_	_	_	_	_
9	presents	_	_	VBZ	_	_	_	_	_
10	some	_	_	DT	_	_	_	_	_
11	disadvantages	_	_	NNS	_	_	_	_	_
12	such	_	_	JJ	_	_	_	_	_
13	as	_	_	IN	_	_	_	_	_
14	poor	_	_	JJ	_	_	_	_	_
15	mechanical	_	_	JJ	_	_	_	_	_
16	properties	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	poor	_	_	JJ	_	_	_	_	_
19	solubility	_	_	NN	_	_	_	_	_
20	in	_	_	IN	_	_	_	_	_
21	conventional	_	_	JJ	_	_	_	_	_
22	solvents	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	poor	_	_	JJ	_	_	_	_	_
26	stability	_	_	NN	_	_	_	_	_
27	in	_	_	IN	_	_	_	_	_
28	physiological	_	_	JJ	_	_	_	_	_
29	media	_	_	NNS	_	_	_	_	_
30	due	_	_	JJ	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	high	_	_	JJ	_	_	_	_	_
34	amount	_	_	NN	_	_	_	_	_
35	of	_	_	IN	_	_	_	_	_
36	hydrogen	_	_	NN	_	_	_	_	_
37	bonding	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	addressed	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	physicochemical	_	_	JJ	_	_	_	_	_
6	attributes	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	nanocomposite	_	_	NN	_	_	_	_	_
9	polymers	_	_	NNS	_	_	_	_	_
10	thanks	_	_	NNS	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	their	_	_	PRP$	_	_	_	_	_
13	effectiveness	_	_	NN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	overcoming	_	_	VBG	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	disadvantages	_	_	NNS	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	naturally	_	_	RB	_	_	_	_	_
20	occurring	_	_	VBG	_	_	_	_	_
21	polymers	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Our	_	_	PRP$	_	_	_	_	_
2	group	_	_	NN	_	_	_	_	_
3	investigated	_	_	VBD	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	use	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	nanocomposites	_	_	NNS	_	_	_	_	_
8	based	_	_	VBN	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	graphene	_	_	NN	_	_	_	_	_
11	oxide	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	chitosan	_	_	NN	_	_	_	_	_
14	for	_	_	IN	_	_	_	_	_
15	applications	_	_	NNS	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	tissue	_	_	NN	_	_	_	_	_
18	engineering	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Even	_	_	RB	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	nanofillers	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	there	_	_	EX	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	still	_	_	RB	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	need	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	achieve	_	_	VB	_	_	_	_	_
13	better	_	_	JJR	_	_	_	_	_
14	mechanical	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	thermal	_	_	JJ	_	_	_	_	_
17	stability	_	_	NN	_	_	_	_	_
18	combined	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	higher	_	_	JJR	_	_	_	_	_
21	biocompatibility	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	nanocomposites	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	chitosan	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	carbon	_	_	NN	_	_	_	_	_
28	nanomaterials	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Carbon	_	_	NN	_	_	_	_	_
2	nano-onions	_	_	NNS	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	CNOs	_	_	NNS	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	multi-shell	_	_	JJ	_	_	_	_	_
8	fullerenes	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	5	_	_	CD	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	10	_	_	CD	_	_	_	_	_
13	nm	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	discovered	_	_	VBN	_	_	_	_	_
16	by	_	_	IN	_	_	_	_	_
17	Ugarte	_	_	NNP	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	1992	_	_	CD	_	_	_	_	_
20	upon	_	_	IN	_	_	_	_	_
21	impacting	_	_	VBG	_	_	_	_	_
22	carbon	_	_	NN	_	_	_	_	_
23	nanostructures	_	_	NNS	_	_	_	_	_
24	with	_	_	IN	_	_	_	_	_
25	an	_	_	DT	_	_	_	_	_
26	electron	_	_	NN	_	_	_	_	_
27	beam	_	_	NN	_	_	_	_	_
28	through	_	_	IN	_	_	_	_	_
29	a	_	_	DT	_	_	_	_	_
30	TEM	_	_	NN	_	_	_	_	_
31	experiment	_	_	NN	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	chemical	_	_	JJ	_	_	_	_	_
4	derivatization	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	CNOs	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	various	_	_	JJ	_	_	_	_	_
9	synthetic	_	_	JJ	_	_	_	_	_
10	routes	_	_	NNS	_	_	_	_	_
11	were	_	_	VBD	_	_	_	_	_
12	applied	_	_	VBN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	introducing	_	_	VBG	_	_	_	_	_
15	new	_	_	JJ	_	_	_	_	_
16	functional	_	_	JJ	_	_	_	_	_
17	groups	_	_	NNS	_	_	_	_	_
18	that	_	_	WDT	_	_	_	_	_
19	increase	_	_	VBP	_	_	_	_	_
20	their	_	_	PRP$	_	_	_	_	_
21	application	_	_	NN	_	_	_	_	_
22	possibilities	_	_	NNS	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Some	_	_	DT	_	_	_	_	_
2	potential	_	_	JJ	_	_	_	_	_
3	uses	_	_	NNS	_	_	_	_	_
4	include	_	_	VBP	_	_	_	_	_
5	optical	_	_	JJ	_	_	_	_	_
6	applications	_	_	NNS	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	catalysis	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	gas	_	_	NN	_	_	_	_	_
12	storage	_	_	NN	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	CNOs	_	_	NNS	_	_	_	_	_
2	are	_	_	VBP	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	useful	_	_	JJ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	photovoltaic	_	_	JJ	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	fuel	_	_	NN	_	_	_	_	_
9	cell	_	_	NN	_	_	_	_	_
10	applications	_	_	NNS	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	demonstrated	_	_	VBD	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	superior	_	_	JJ	_	_	_	_	_
5	lubrication	_	_	NN	_	_	_	_	_
6	ability	_	_	NN	_	_	_	_	_
7	compared	_	_	VBN	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	conventional	_	_	JJ	_	_	_	_	_
10	lubricants	_	_	NNS	_	_	_	_	_
11	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	there	_	_	EX	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	few	_	_	JJ	_	_	_	_	_
6	reports	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	CS	_	_	NNP	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	CNO	_	_	NNP	_	_	_	_	_
11	composites	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	literature	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	electrochemical	_	_	JJ	_	_	_	_	_
3	properties	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	composites	_	_	NNS	_	_	_	_	_
6	consisting	_	_	VBG	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	CNOs	_	_	NNS	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	poly(diallyl	_	_	JJ	_	_	_	_	_
11	dimethylammonium	_	_	NN	_	_	_	_	_
12	chloride	_	_	NN	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	(	_	_	-LRB-	_	_	_	_	_
15	PDDA	_	_	NN	_	_	_	_	_
16	)	_	_	-RRB-	_	_	_	_	_
17	or	_	_	CC	_	_	_	_	_
18	chitosan	_	_	NN	_	_	_	_	_
19	(	_	_	-LRB-	_	_	_	_	_
20	CS	_	_	NNP	_	_	_	_	_
21	)	_	_	-RRB-	_	_	_	_	_
22	were	_	_	VBD	_	_	_	_	_
23	reported	_	_	VBN	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	lack	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	literature	_	_	NN	_	_	_	_	_
5	regarding	_	_	VBG	_	_	_	_	_
6	nanocomposites	_	_	NNS	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	CS	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	oxidized	_	_	VBN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	ox-)CNOs	_	_	NNS	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	biomedical	_	_	JJ	_	_	_	_	_
15	applications	_	_	NNS	_	_	_	_	_
16	is	_	_	VBZ	_	_	_	_	_
17	evident	_	_	JJ	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Very	_	_	RB	_	_	_	_	_
2	few	_	_	JJ	_	_	_	_	_
3	studies	_	_	NNS	_	_	_	_	_
4	were	_	_	VBD	_	_	_	_	_
5	carried	_	_	VBN	_	_	_	_	_
6	out	_	_	RP	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	determine	_	_	VB	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	cytotoxicity	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	CNOs	_	_	NNPS	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	were	_	_	VBD	_	_	_	_	_
3	even	_	_	RB	_	_	_	_	_
4	used	_	_	VBN	_	_	_	_	_
5	for	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	treatment	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	cancer	_	_	NN	_	_	_	_	_
10	;	_	_	:	_	_	_	_	_
11	however	_	_	RB	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	many	_	_	JJ	_	_	_	_	_
14	more	_	_	JJR	_	_	_	_	_
15	studies	_	_	NNS	_	_	_	_	_
16	are	_	_	VBP	_	_	_	_	_
17	still	_	_	RB	_	_	_	_	_
18	required	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	show	_	_	VB	_	_	_	_	_
21	whether	_	_	IN	_	_	_	_	_
22	they	_	_	PRP	_	_	_	_	_
23	are	_	_	VBP	_	_	_	_	_
24	toxic	_	_	JJ	_	_	_	_	_
25	or	_	_	CC	_	_	_	_	_
26	if	_	_	IN	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	on	_	_	IN	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	contrary	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	they	_	_	PRP	_	_	_	_	_
33	promote	_	_	VBP	_	_	_	_	_
34	cell	_	_	NN	_	_	_	_	_
35	adhesion	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	proliferation	_	_	NN	_	_	_	_	_
38	,	_	_	,	_	_	_	_	_
39	while	_	_	IN	_	_	_	_	_
40	facilitating	_	_	VBG	_	_	_	_	_
41	the	_	_	DT	_	_	_	_	_
42	recognition	_	_	NN	_	_	_	_	_
43	and	_	_	CC	_	_	_	_	_
44	permanence	_	_	NN	_	_	_	_	_
45	of	_	_	IN	_	_	_	_	_
46	scaffolds	_	_	NNS	_	_	_	_	_
47	in	_	_	IN	_	_	_	_	_
48	animal	_	_	NN	_	_	_	_	_
49	tissues	_	_	NNS	_	_	_	_	_
50	without	_	_	IN	_	_	_	_	_
51	immune	_	_	JJ	_	_	_	_	_
52	responses	_	_	NNS	_	_	_	_	_
53	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	lack	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	information	_	_	NN	_	_	_	_	_
7	on	_	_	IN	_	_	_	_	_
8	their	_	_	PRP$	_	_	_	_	_
9	characterization	_	_	NN	_	_	_	_	_
10	including	_	_	VBG	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	physical	_	_	JJ	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	chemical	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	mechanical	_	_	JJ	_	_	_	_	_
18	evaluation	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	nanocomposite	_	_	NN	_	_	_	_	_
21	films	_	_	NNS	_	_	_	_	_
22	based	_	_	VBN	_	_	_	_	_
23	on	_	_	IN	_	_	_	_	_
24	CS/poly(vinyl	_	_	NNP	_	_	_	_	_
25	alcohol	_	_	NN	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	(	_	_	-LRB-	_	_	_	_	_
28	PVA)/ox-CNO	_	_	NNP	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	together	_	_	RB	_	_	_	_	_
31	with	_	_	IN	_	_	_	_	_
32	biological	_	_	JJ	_	_	_	_	_
33	tests	_	_	NNS	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	vitro	_	_	NN	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	vivo	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	investigation	_	_	NN	_	_	_	_	_
6	will	_	_	MD	_	_	_	_	_
7	allow	_	_	VB	_	_	_	_	_
8	collecting	_	_	VBG	_	_	_	_	_
9	toxicological	_	_	JJ	_	_	_	_	_
10	information	_	_	NN	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	these	_	_	DT	_	_	_	_	_
13	nanocomposites	_	_	NNS	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	as	_	_	RB	_	_	_	_	_
16	well	_	_	RB	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	evaluating	_	_	VBG	_	_	_	_	_
19	their	_	_	PRP$	_	_	_	_	_
20	possible	_	_	JJ	_	_	_	_	_
21	application	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	tissue	_	_	NN	_	_	_	_	_
24	engineering	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Therefore	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	this	_	_	DT	_	_	_	_	_
4	research	_	_	NN	_	_	_	_	_
5	investigates	_	_	VBZ	_	_	_	_	_
6	nanocomposite	_	_	JJ	_	_	_	_	_
7	films	_	_	NNS	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	PVA/CS	_	_	NNP	_	_	_	_	_
10	reinforced	_	_	VBN	_	_	_	_	_
11	with	_	_	IN	_	_	_	_	_
12	ox-CNOs	_	_	NNS	_	_	_	_	_
13	for	_	_	IN	_	_	_	_	_
14	biocompatibility	_	_	NN	_	_	_	_	_
15	studies	_	_	NNS	_	_	_	_	_
16	at	_	_	IN	_	_	_	_	_
17	90	_	_	CD	_	_	_	_	_
18	days	_	_	NNS	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	subdermal	_	_	JJ	_	_	_	_	_
21	implantation	_	_	NN	_	_	_	_	_
22	in	_	_	IN	_	_	_	_	_
23	biomodel	_	_	NN	_	_	_	_	_
24	skin	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_

